Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.

M, Sabaté; P, Jiménez-Quevedo; DJ, Angiolillo; JA, Gómez-Hospital; F, Alfonso; R, Hernández-Antolín; J, Goicolea; C, Bañuelos; J, Escaned; R, Moreno; C, Fernández; F, Fernández-Avilés; C, Macaya

doi:10.1161/circulationaha.105.562421

Public

Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.

Shared by NobleBlocks on Oct 1, 2005 • 12:00 AM UTC

Authors:

Sabaté M

Jiménez-Quevedo P

Angiolillo DJ

Abstract

Background Outcomes after percutaneous coronary interventions in diabetic patients are shadowed by the increased rate of recurrence compared with nondiabetic patients.Methods and results We conducted a multicenter, randomized trial to demonstrate the efficacy of sirolimus-eluting stents compared wit...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!